MedTrace Logo

Strength Profile of Hip Joint in Females With Primary Dysmenorrhea During Menstrual Cycle

NCT06615037 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-02-05

No results posted yet for this study

Summary

The goal of this observational study is to investigate the effect of primary dysmenorrhea on strength of hip joint muscles in females.

Conditions

  • Primary Dysmenorrhea

Interventions

OTHER

Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro)

Assessment of the strength of hip flexors and extensors muscles: * Participants will be in a supine-lying position, the highest reliability (ICC = 0.90) according to the results of the meta-analysis (Contreras et al., 2021). * Seat orientation 0°. * Dynamometer tilt 0° and orientation 0°. * The axis of the dynamometer on the greater trochanter of the femur. * The test parameters included a 0-90 degree range of motion. * During the isokinetic testing movement, the hip was first flexed from a neutral (starting) position to 90° (for hip flexion) and then the direction of the movement was reversed (for hip extension) * Angular speed at 120°/s which shows excellent reliability (ICC = 95%) with concentric contraction mode (Contreras et al., 2021) .

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nourhan Mohamed Mitwally Amer · Bachelor Physical Therapy- MUST

  • Amal Mohamed Yousef, Professor · Cairo University

  • Mai Mohamed Ali, Lecturer · Cairo University

  • Ehab Kamal Mohamed Younis, lecturer · Lecturer of obstetrics and gynecology - Faculty of Medicine - Misr university for science and technology

Eligibility

Min Age
20 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-01-15
Completion
2025-01-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06615037 on ClinicalTrials.gov